Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report

PURPOSE: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. OBSERVATION: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Boontantrapiwat, Sinsucha, Rojanaporn, Duangnate, Chokthaweesak, Weerawan, Kitnarong, Naris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479422/
https://www.ncbi.nlm.nih.gov/pubmed/36128343
http://dx.doi.org/10.1016/j.ajoc.2022.101707
Descripción
Sumario:PURPOSE: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. OBSERVATION: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment with favipiravir, intravenous dexamethasone, and ceftriaxone. An ocular examination of her right eye revealed periorbital tenderness, exophthalmos, and corneal haze. The ultrasonography showed a subretinal abscess. Her right eye lost light perception vision and underwent enucleation. Microbiologic evaluation of the enucleated right eye was negative for organisms. CONCLUSIONS AND IMPORTANCE: Patents with COVID-19 may develop severe ocular involvement after COVID-19 due to a generalized reduction in immunity. Comorbidities and intensive care unit treatments can predispose COVID-19 patients to endogenous panophthalmitis.

Ejemplares similares